When the Float Vanishes: 97% Institutional Ownership Leaves Little Room to Trade

Mild Accumulation Amid Insider Sales Signals a Tight‑Holding Landscape

MD Pediatrix Medical Group, Inc.

In this report

01

Institutional Ownership

Quarterly ownership trends, direction, investor count

→

02

Position Flow Analysis

Flow ratio, conviction, new vs closed positions

→

03

Float & Options Context

Put/call ratio, free float estimate, hedging activity

→

04

Insider Trading Patterns

Insider buys/sells, top transactions, cluster buying, post-buy returns

→

05

Smart Money Summary

Convergence/divergence flags, key takeaways

→

Institutional Ownership Trends

Pediatrix Medical Group, Inc. (MD) — Ownership Profile

Pediatrix Medical Group, Inc. (MD) exhibits a highly institutionalized ownership structure, with current institutional ownership at 96.8%, well above the 90% threshold that signals a constrained public float. Over the past year, ownership increased by 3.26 percentage points, but the change is classified as stable because there has been no consecutive quarterly increase; the most recent quarter showed a decline after one prior rise, resulting in only a single quarter of accumulation and one quarter of distribution.

Ownership Overview

MD

The institution base remains dominant, reflected by 293 institutional investors, yet the count has not shifted materially, indicating no significant entry or exit of large holders. The modest 3.26pp rise does not meet the three‑quarter threshold for sustained accumulation, suggesting that while institutions are slightly increasing their stake, the trend is not yet decisive. Given the float constraints at 96.8% ownership, any further institutional buying could pressure liquidity, whereas a reversal toward distribution would likely have limited impact on share price volatility.

Position Flow Analysis

Pediatrix Medical Group, Inc. (MD) — Position Flows

Pediatrix Medical Group, Inc. (MD) exhibits a mild accumulation pattern with a current flow ratio of 1.29, placing it within the 1.0‑1.5 range that signals net buying but not at a strong level. The conviction ratio sits at 0.6, just meeting the threshold for existing holders adding to their positions, indicating modest confidence among current institutional investors. Together these metrics suggest that institutions are both opening new positions and reinforcing existing stakes, albeit at a measured pace.

Position Flow Metrics

MD

The flow ratio of 1.29 points to mild net accumulation, meaning fresh capital is flowing into the stock but not at an aggressive rate. A conviction ratio of 0.6 signals that existing institutional holders are marginally increasing their exposure, reinforcing confidence in the business outlook. The latest net flow figure of 42 (presumably million shares) corroborates a modest inflow, indicating balanced activity rather than a sharp shift.

Float & Options Context

Pediatrix Medical Group, Inc. (MD) — Float & Options

Pediatrix Medical Group, Inc. (MD) exhibits an extremely constrained free float of approximately 3.2%, derived from a very high institutional ownership level of 96.8%. The put/call ratio stands at 0.0 and is reported as stable, indicating virtually no put activity relative to calls and suggesting that option traders are not hedging bearish positions; the absence of puts points to a call‑heavy or neutral stance rather than defensive positioning.

Float & Options Overview

MD

The negligible put/call ratio (0.0) signals that market participants with option exposure are not expressing downside risk, which aligns with the confidence of institutional holders who control most of the shares. However, the ultra‑low free float (<15%) creates a structural constraint on liquidity; any unexpected selling pressure could trigger amplified price moves or short‑squeeze dynamics, especially if insiders or large shareholders decide to transact.

Float & Options Context

Pediatrix Medical Group, Inc. (MD) — Put/Call Ratio

Insider Trading Patterns

Pediatrix Medical Group, Inc. (MD) — Insider Activity

Over the past twelve months, insiders at Pediatrix Medical Group, Inc. have exclusively sold shares, recording four sell transactions totaling $1.83 million and no purchases, resulting in a buy/sell value ratio of 0.0—well below the 0.2 threshold that flags heavy insider selling. The most material sales were executed by Director/CEO Mark S. Ordan ($515,430 on 2025‑12‑15) and Director Shirley A. Weis ($855,665 on 2026‑05‑13), suggesting that senior management is reducing their holdings, albeit the amounts are consistent with typical equity compensation or diversification activities.

Insider Activity Summary

MD

The pattern of exclusive insider selling, especially by the CEO and a board director, indicates a net disposition of stock that may be viewed as mildly bearish. However, given the absence of clustered sales within short windows and the likelihood that these disposals are linked to routine compensation or tax planning, the signal should be interpreted cautiously rather than as a definitive negative outlook.

Insider Trading Patterns

Pediatrix Medical Group, Inc. (MD) — Insider Timeline

Smart Money Summary

Pediatrix Medical Group, Inc. (MD) — Summary & Implications

Institutional ownership of Pediatrix Medical Group, Inc. (MD) is extremely high at 96.8%, having risen by 3.26 percentage points over the last quarter. The flow classification of mild accumulation and a conviction score of 0.6 indicate that institutions are modestly adding to their positions, reflecting confidence in the company’s near‑term prospects while still leaving limited float for further inflows. Insider activity shows a net zero balance (P/C Ratio 0.0) with no recent purchases and some selling; however, the selling appears routine rather than distress‑driven, as insiders often liquidate shares for tax or compensation purposes.

Smart Money Dashboard

Key Takeaways

Institutional ownership is at an unusually high 96.8%, limiting additional inflows from new investors.
Institutions have increased their stake by 3.26pp in the last quarter, indicating mild accumulation confidence.
Insider activity shows net selling with a zero purchase ratio, but the volume aligns with typical compensation‑related sales.
The divergence between institutional buying and insider selling suggests differing short‑term expectations among large shareholders.
Overall smart money positioning reflects cautious optimism from institutions tempered by routine insider sell-offs.

MD

Smart money signals are mixed: institutional investors are gently accumulating a near‑saturated float, suggesting measured optimism, while insider selling introduces a divergence that may temper enthusiasm. The convergence of high ownership and modest accumulation points to confidence among large holders, but the lack of insider buying tempers the bullish narrative.

MD

Related Reports

Explore more at Finexus Reports

Report written 2026-06-07 • Finexus

Disclaimer

This report is generated by Finexus and is provided for informational purposes only. It does not constitute investment advice, a recommendation, or an offer or solicitation to buy or sell any security.

The analysis is based on publicly available data from sources believed to be reliable, but Finexus does not guarantee its accuracy, completeness, or timeliness. Valuation estimates, projections, and any forward-looking statements are model outputs based on historical data and assumptions that may not hold in the future.

Past performance is not indicative of future results. Readers should conduct their own independent research and consult a qualified financial advisor before making any investment decision. Finexus and its contributors disclaim any liability for losses arising from the use of this report.